Effect of Anti-IL5, Anti-IL5R, Anti-IL13 Therapy on Asthma Exacerbations: A Network Meta-analysis

Background Several new treatments for severe asthma have become available in the last decade; yet, little data exist to guide their use in specific patient populations. Objective A network meta-analysis was conducted comparing the efficacy of FDA-approved monoclonal antibody therapies in preventing...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Lung 2020-02, Vol.198 (1), p.95-103
Hauptverfasser:	Ramonell, Richard P., Iftikhar, Imran H.
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Asthmatic Agents - therapeutic use Antibodies, Monoclonal, Humanized - therapeutic use Asthma Asthma - drug therapy Asthma - immunology Asthma - physiopathology Diagnosis Disease Progression Eosinophilia - drug therapy Eosinophilia - immunology Eosinophilia - physiopathology Eosinophils Health aspects Humans Interleukin-13 - antagonists & inhibitors Interleukin-4 Receptor alpha Subunit - antagonists & inhibitors Interleukin-5 - antagonists & inhibitors Interleukin-5 Receptor alpha Subunit - antagonists & inhibitors Interleukins Medicine Medicine & Public Health Network Meta-Analysis Pneumology/Respiratory System Randomized Controlled Trials as Topic Secondary Prevention
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!